COMMUNIQUÉS West-GlobeNewswire

Prime Biome Reviewed: A Prime Biome Expert's Guide to Avoiding Fakes and Ensuring Authenticity
19/03/2025
ST. PETERSBURG, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a leading skin and gut microbiome rejuvenation supplement that has taken the wellness world by storm. This innovative formula—offered as delicious [...]
Arialief Reviews 2025: Consumer Reports on Arialief Nerve Health Supplement
19/03/2025
AURORA, Colo., March 19, 2025 (GLOBE NEWSWIRE) -- Arialief is quickly gaining a reputation as a transformational supplement in the field of nerve health. For years, those suffering from neuropathy, sciatica, and chronic [...]
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
19/03/2025
Femasys continues to expand access and market share for its first-line infertility treatment option ATLANTA, March 19, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing [...]
Iridex Announces Strategic Investment in the Company
19/03/2025
MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of [...]
Healthcare Integrated Technologies Inc. Announces First School Partnership for SafeSpace AI Platform - SafeSchool
19/03/2025
Brentwood Academy in Nashville, TN will Launch Advanced Safety Measures Knoxville, TN, March 19, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and [...]
Revive Therapeutics Announces Results of Annual Shareholder Meeting
19/03/2025
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of [...]
Capsa Healthcare Unveils Cutting-Edge Innovation Center, Elevating Collaborative Healthcare Solutions
19/03/2025
New facility offers immersive experiences with advanced point-of-care and pharmacy automation technologies. COLUMBUS, Ohio, March 19, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a pioneer in medication management, [...]
Jushi Holdings Inc. Announces Ohio Retail Updates Including the Opening of Beyond Hello™ Warren, Expanding Its Presence in Ohio’s Emerging Adult-Use Market
19/03/2025
New Beyond Hello™ Adult-Use and Medical Dispensary Opens in Warren, OH Strengthening Jushi’s Ohio Retail Presence with Fourth Dispensary in the State Grand Opening Celebration with Exclusive Promotions on March 20, 2025 [...]
Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
19/03/2025
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) ( [...]
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension
19/03/2025
Monopoint system enables rapid access to the venous system Research to be presented at SNIS Cerebral Venous and CSF Disorders Summit SAN MATEO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a [...]
NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th
19/03/2025
Management will host a conference call at 4:30 p.m. ET on the same day LANGHORNE, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, [...]
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
19/03/2025
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA Treatment with investigational OAV101 IT led to statistically [...]
Lipozem Reviews (Is It Safe And Legit To Use?) Ingredients, Side Effect Complaints, And Weight Loss Benefits!
19/03/2025
LAKELAND, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- Lipozem is a weight loss supplement crafted to support burning fat without causing adverse or side effects. It contains carefully selected ingredients that activate [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
19/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 19 MARCH 2025 at 14.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Lirum Therapeutics Invited to Present at Prestigious Gordon Research Conference
19/03/2025
New York, NY, March 19, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that the [...]
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session
19/03/2025
Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: [...]
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
19/03/2025
Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, formulation optimization, and IP expansion, positioning the Company for near- [...]
Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
19/03/2025
ROCKVILLE, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high [...]
FDA Clears Magstim Transcranial Magnetic Stimulation System for U.S. Adolescent Patient Treatment
19/03/2025
Adolescent patients ages 15-21 can now receive non-invasive TMS for treatment of major depressive disorder (MDD)* MINNEAPOLIS, March 19, 2025 (GLOBE NEWSWIRE) -- Major depression impacts more than 5 million U.S. [...]

Pages